Palisade Bio PALI Institutional Ownership

Updated Oct 10, 2026

Palisade Bio, Inc. (NASDAQ:PALI) had 125 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Their combined stake equaled 82.02% of outstanding shares in Q2 2026, up from 69.96% in Q1 2026.
• Shares of PALI held in total rose 18.20% from Q1 2026.
• Looking at the 125 holders of PALI individually, 85 added to their positions, 23 reduced their stakes and 17 left their positions unchanged.
• The aggregate institutional position in Palisade Bio was 173.39Mn shares at the end of Q2 2026, up 26.7Mn from the prior quarter and up 173.3Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Palisade Bio was Soleus Capital Management, L.P. with 13.06Mn shares, or 6.18% of shares outstanding.
• Among existing holders, the largest additions to Palisade Bio in Q2 2026 came from BlackRock, Inc. (+8.56Mn shares), Point72 Asset Management, L.P. (+4.84Mn shares), Ameriprise Financial Inc (+2.37Mn shares), Geode Capital Management, LLC (+2.21Mn shares) and State Street Corp (+1.84Mn shares).
• The biggest cuts to PALI positions during Q2 2026 came from Marshall Wace, LLP (-2.36Mn shares), Morgan Stanley (-2.08Mn shares), Goldman Sachs Group Inc (-1.8Mn shares), Balyasny Asset Management L.P. (-1.4Mn shares) and Millennium Management LLC (-1.17Mn shares).
• Palisade Bio's 10 largest institutional shareholders as of Q2 2026 were Soleus Capital Management, L.P. (13.06Mn shares), B Group, Inc. (11.41Mn shares), Ameriprise Financial Inc (11.08Mn shares), Jupiter Topco LLC (10.69Mn shares), BlackRock, Inc. (10.44Mn shares), Octagon Capital Advisors LP (10.28Mn shares), Perceptive Advisors LLC (8.43Mn shares), Ra Capital Management, L.P. (7.12Mn shares), Franklin Templeton Inc (5.79Mn shares) and Point72 Asset Management, L.P. (5.25Mn shares), per Business Quant data.